Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $16.57 in the prior trading day, Adma Biologics Inc (NASDAQ: ADMA) closed at $16.87, up 1.81%. In other words, the price has increased by $1.81 from its previous closing price. On the day, 2.79 million shares were traded. ADMA stock price reached its highest trading level at $16.93 during the session, while it also had its lowest trading level at $16.06.
Ratios:
Our goal is to gain a better understanding of ADMA by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 44.56 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 59.00. For the most recent quarter (mrq), Quick Ratio is recorded 2.80 and its Current Ratio is at 6.87. In the meantime, Its Debt-to-Equity ratio is 0.75 whereas as Long-Term Debt/Eq ratio is at 0.74.
On October 13, 2022, Mizuho started tracking the stock assigning a Buy rating and target price of $5.
Raymond James Upgraded its Outperform to Strong Buy on November 11, 2021, while the target price for the stock was maintained at $5.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 30 ’24 when Kestenberg-Messina Kaitlin M. sold 24,150 shares for $16.90 per share. The transaction valued at 408,050 led to the insider holds 449,088 shares of the business.
Grossman Jerrold B sold 136,861 shares of ADMA for $2,363,932 on Aug 29 ’24. The Director now owns 467,305 shares after completing the transaction at $17.27 per share. On Aug 30 ’24, another insider, Kestenberg-Messina Kaitlin M., who serves as the Officer of the company, bought 24,150 shares for $17.22 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ADMA now has a Market Capitalization of 3932110592 and an Enterprise Value of 3915336448. As of this moment, Adma’s Price-to-Earnings (P/E) ratio for their current fiscal year is 119.99, and their Forward P/E ratio for the next fiscal year is 25.76. For the stock, the TTM Price-to-Sale (P/S) ratio is 11.91 while its Price-to-Book (P/B) ratio in mrq is 20.88. Its current Enterprise Value per Revenue stands at 11.856 whereas that against EBITDA is 41.174.
Stock Price History:
Over the past 52 weeks, ADMA has reached a high of $18.48, while it has fallen to a 52-week low of $3.06. The 50-Day Moving Average of the stock is 20.77%, while the 200-Day Moving Average is calculated to be 107.11%.
Shares Statistics:
The stock has traded on average 3.56M shares per day over the past 3-months and 3123390 shares per day over the last 10 days, according to various share statistics. A total of 226.06M shares are outstanding, with a floating share count of 225.17M. Insiders hold about 3.40% of the company’s shares, while institutions hold 77.87% stake in the company. Shares short for ADMA as of 1723680000 were 9015280 with a Short Ratio of 2.53, compared to 1721001600 on 8277360. Therefore, it implies a Short% of Shares Outstanding of 9015280 and a Short% of Float of 3.9800000000000004.
